Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).
about
HIV-1 Vaccine Trials: Evolving Concepts and DesignsHuman tetherin exerts strong selection pressure on the HIV-1 group N Vpu protein.Brief Report: HIV-1 gp120 T-Cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemoprophylaxis TrialRecent 5-year Findings and Technological Advances in the Proteomic Study of HIV-associated Disorders.NK cell responses to simian immunodeficiency virus vaginal exposure in naive and vaccinated rhesus macaquesMucosal correlates of protection in HIV-1-exposed sero-negative persons.Anti-gp120 minibody gene transfer to female genital epithelial cells protects against HIV-1 virus challenge in vitro.Mucosal immunity in the female genital tract, HIV/AIDSAnti-HIV-1 activity of elafin depends on its nuclear localization and altered innate immune activation in female genital epithelial cells.Epitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations.Upregulation of innate antiviral restricting factor expression in the cord blood and decidual tissue of HIV-infected mothers.Innate activation of MDC and NK cells in high-risk HIV-1-exposed seronegative IV-drug users who share needles when compared with low-risk nonsharing IV-drug user controls.Involvement of neutrophil hyporesponse and the role of Toll-like receptors in human immunodeficiency virus 1 protectionImpaired NK Cell Activation and Chemotaxis toward Dendritic Cells Exposed to Complement-Opsonized HIV-1.NK and CD4+ T cell cooperative immune responses correlate with control of disease in a macaque simian immunodeficiency virus infection model.Natural Immunity to HIV: a delicate balance between strength and control.The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life.Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohortAntiviral factors and type I/III interferon expression associated with regulatory factors in the oral epithelial cells from HIV-1-serodiscordant couples.Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 InfectionReducing IRF-1 to Levels Observed in HESN Subjects Limits HIV Replication, But Not the Extent of Host Immune Activation.Prevention of SHIV transmission by topical IFN-β treatment.Neonatal natural killer cell function: relevance to antiviral immune defenseDifferential regulatory T cell activity in HIV type 1-exposed seronegative individuals.Previously Unidentified Single Nucleotide Polymorphisms in HIV/AIDS Cases Associate with Clinical Parameters and Disease Progression.Serial cervicovaginal exposures with replication-deficient SIVsm induce higher dendritic cell (pDC) and CD4+ T-cell infiltrates not associated with prevention but a more severe SIVmac251 infection of rhesus macaques.Role of KIR3DS1 in human diseases.Peginterferon α-2a for the treatment of HIV infection.Role of Different Subpopulations of CD8+ T Cells during HIV Exposure and Infection.Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load.Natural killer cells in highly exposed hepatitis C-seronegative injecting drug users.Phenotypic and Functional Characterization of Circulatory, Splenic, and Hepatic NK Cells in Simian Immunodeficiency Virus-Controlling Macaques.Acting locally: innate mucosal immunity in resistance to HIV-1 infection in Kenyan commercial sex workers.Complement-Opsonized HIV-1 Alters Cross Talk Between Dendritic Cells and Natural Killer (NK) Cells to Inhibit NK Killing and to Upregulate PD-1, CXCR3, and CCR4 on T Cells.Decreased levels of serum complement C3 and natural killer cells add to the predictive value of total immunoglobulin G for severe infection in heart transplant recipientsA distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers
P2860
Q30425520-4C7851B1-3F6C-43B6-A6CD-DD863E928189Q30425799-0C95F7BA-EAA3-4BAB-9AFD-41C446F5D83FQ33574027-F00AD20A-9B4A-4E2B-A864-1DDB55C22844Q33633451-188C5AD3-7152-43EA-A1A3-F3E4C9E3739CQ33851763-30DB52A2-201D-422E-A653-D283B868AEFDQ33911540-CF83ADE3-91B0-4407-9ED8-BFDC0CD59E14Q34059643-E28A3589-5B28-48FD-80AB-F3547F2CCB5BQ34275424-39615CA4-6535-4AFE-9BCE-2AC4BEA3CFAFQ34541093-FB572BDA-A396-441C-9166-E58B8DA030F2Q34548297-EB8B4B2D-0175-4B26-9AC1-F1099A162208Q35075884-778776A4-EA04-4A81-9638-11F45317EB0AQ35085106-A44372F0-5359-4DE9-B5DD-EF18F938C93FQ35192491-2DA336F1-EA58-42F3-82F7-92C0CEF01079Q35925669-5CCD1792-C604-4D12-A709-6F7F96A430B7Q36140156-F98BF606-998E-472D-AE3E-88EC5CF9A06BQ36487755-B5E94AEB-8CAA-4FAA-BEF1-EA25B6D8DDEAQ36496904-63509C79-7300-4164-AF85-728CF2728D13Q36866176-1223215A-8BB1-49F8-80E0-1B0DFCA4FC81Q36889962-19E42A53-7C91-48A0-8AF5-5FF6B282DB3FQ36900870-920AE146-F2A2-48DA-AF66-EF9A56D9EA13Q36939732-0E0767CE-3E7E-45AB-855B-855286761B84Q37150111-A8F8C9CC-F9D2-4E60-822C-81F2A2C24450Q37162875-6B7E10F4-8090-429D-A764-BDC33575C59EQ37204127-345A17E2-D968-445A-8944-86527CF975B8Q37512562-E64522CA-9205-4ECE-8FD6-0377E25B23A7Q37619686-367E90E1-58CC-44EA-BB8D-779473853CC2Q38057745-ACFC3F17-1D36-44E3-97D5-1C3FFD552F64Q38669306-1006B80C-E155-4600-A54A-F105316EF4A8Q40077061-7E449D5D-5F56-4B72-BD09-94CCC10AE28CQ40125669-E654EE9B-189A-4968-89BD-B06320D65D03Q40809341-4A8DC2AD-507E-44A4-8B6D-BB9FCFDB43C4Q41930380-BB6269A6-3AD4-49D9-875F-3F9EDD0B0672Q42257475-021D6C0D-7C4E-4D3A-843C-1EA6DEBF13DBQ54211943-40262370-9F01-4849-89A6-978C663BB006Q57568967-47A13512-3848-42A0-A391-16803B51A443Q57766050-003FABA1-0D84-4B1F-9A4F-39EA1E3E2965
P2860
Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evidence for the innate immune ...... seronegative subjects (HESN).
@en
Evidence for the innate immune ...... n human immunodeficiency virus
@nl
type
label
Evidence for the innate immune ...... seronegative subjects (HESN).
@en
Evidence for the innate immune ...... n human immunodeficiency virus
@nl
prefLabel
Evidence for the innate immune ...... seronegative subjects (HESN).
@en
Evidence for the innate immune ...... n human immunodeficiency virus
@nl
P2093
P2860
P1476
Evidence for the innate immune ...... seronegative subjects (HESN).
@en
P2093
L J Montaner
S Abdulhaqq
P2860
P304
P356
10.1111/J.1365-2249.2011.04379.X
P577
2011-03-17T00:00:00Z